These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25082649)

  • 1. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
    Fujimaru T; Ito S; Masuda H; Oana S; Kamei K; Ishiguro A; Kato H; Abe J
    Cytokine; 2014 Dec; 70(2):156-60. PubMed ID: 25082649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
    Mori M; Imagawa T; Hara R; Kikuchi M; Hara T; Nozawa T; Miyamae T; Yokota S
    J Rheumatol; 2012 Apr; 39(4):864-7. PubMed ID: 22337241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin].
    Mori M
    Nihon Rinsho; 2008 Feb; 66(2):349-54. PubMed ID: 18260334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease.
    Hokosaki T; Mori M; Nishizawa T; Nakamura T; Imagawa T; Iwamoto M; Yokota S
    Pediatr Int; 2012 Feb; 54(1):99-103. PubMed ID: 22004042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytokines in Kawasaki disease].
    Abe J
    Nihon Rinsho; 2014 Sep; 72(9):1548-53. PubMed ID: 25518401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.
    Hachiya A; Kobayashi N; Matsuzaki S; Takeuchi Y; Akazawa Y; Shigemura T; Motoki N; Masumoto J; Agematsu K
    Clin Rheumatol; 2018 Jul; 37(7):1937-1943. PubMed ID: 29302828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange and infliximab as a third-line therapy for refractory infantile Kawasaki disease.
    Ansai H; Masuda H; Nakao H; Nishimura N; Kubota M
    Pediatr Int; 2022 Jan; 64(1):e15226. PubMed ID: 35831245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
    Masuzawa Y; Mori M; Hara T; Inaba A; Oba MS; Yokota S
    Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease refractory to standard treatments that responds to a combination of pulsed methylprednisolone and plasma exchange: Cytokine profiling and literature review.
    Matsui M; Okuma Y; Yamanaka J; Uryu H; Sato N; Shichino H; Matsushita T
    Cytokine; 2015 Aug; 74(2):339-42. PubMed ID: 25801094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease.
    Hamada H; Suzuki H; Abe J; Suzuki Y; Suenaga T; Takeuchi T; Yoshikawa N; Shibuta S; Miyawaki M; Oishi K; Yamaga H; Aoyagi N; Iwahashi S; Miyashita R; Honda T; Onouchi Y; Terai M; Hata A
    Cytokine; 2012 Dec; 60(3):681-5. PubMed ID: 22944461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.